- Home
- LEE vs ANVS Comparison
LEE vs ANVS Comparison
Compare LEE & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- ANVS
- Stock Information
- Founded
- LEE 1890
- ANVS 2008
- Country
- LEE United States
- ANVS United States
- Employees
- LEE N/A
- ANVS N/A
- Industry
- LEE Newspapers/Magazines
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- ANVS Health Care
- Exchange
- LEE Nasdaq
- ANVS Nasdaq
- Market Cap
- LEE 90.6M
- ANVS 92.6M
- IPO Year
- LEE N/A
- ANVS 2020
- Fundamental
- Price
- LEE $12.15
- ANVS $5.01
- Analyst Decision
- LEE
- ANVS Strong Buy
- Analyst Count
- LEE 0
- ANVS 6
- Target Price
- LEE N/A
- ANVS $29.67
- AVG Volume (30 Days)
- LEE 37.1K
- ANVS 488.6K
- Earning Date
- LEE 01-30-2025
- ANVS 11-08-2024
- Dividend Yield
- LEE N/A
- ANVS N/A
- EPS Growth
- LEE N/A
- ANVS N/A
- EPS
- LEE N/A
- ANVS N/A
- Revenue
- LEE $611,380,000.00
- ANVS N/A
- Revenue This Year
- LEE N/A
- ANVS N/A
- Revenue Next Year
- LEE N/A
- ANVS N/A
- P/E Ratio
- LEE N/A
- ANVS N/A
- Revenue Growth
- LEE N/A
- ANVS N/A
- 52 Week Low
- LEE $7.57
- ANVS $4.21
- 52 Week High
- LEE $19.63
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- LEE 29.32
- ANVS 44.02
- Support Level
- LEE $13.62
- ANVS $4.61
- Resistance Level
- LEE $14.50
- ANVS $4.95
- Average True Range (ATR)
- LEE 0.83
- ANVS 0.38
- MACD
- LEE -0.19
- ANVS 0.07
- Stochastic Oscillator
- LEE 7.43
- ANVS 40.40
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.